Sign inJoin waitlistJoin the waitlist

Back to University of Texas M D Anderson Cancer Center Radiation Oncology

Ansel Nalin

Resident · University of Texas M D Anderson Cancer Center

Credentials: · · ·

History

Radiation Oncology
University of Texas M D Anderson Cancer Center
2024–Present
Resident
University of Texas M D Anderson Cancer Center
Present
Preliminary or Transitional Year
2023–2024
Ohio State University College of Medicine
Ohio State University College of Medicine
2019–2023
University of Notre Dame

Research

First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia
American Journal of Cancer Research · 2018 · 406 citations
The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector
Cancer Discovery · 2019 · 257 citations
The IL-15-AKT-XBP1s signaling pathway contributes to effector functions and survival in human NK cells
Nature Immunology · 2019 · 99 citations

Aharon Freud
11 papers
MC
Michael Caligiuri
9 papers
Dukagjin Blakaj
5 papers
ET
Evan Thomas
5 papers · 1 as a resident
Haley Perlow
5 papers · 3 as a resident
Joshua Palmer
5 papers
Raju Raval
5 papers
Sasha Beyer
5 papers
Daniel Boulter
4 papers
Youssef Youssef
4 papers · 4 as a fellow
AR
Alex Ritter
3 papers · 1 as a resident
Andrea Arnett
3 papers

Grants

The Role of Notch Signaling in Human Natural Killer Cell Functional Maturation
National Cancer Institute · F30
Contact PI · $78.9K · Ohio State University
2019–2021